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Abstract
Green tea catechins (GTC) reduce UV radiation (UVR)-induced inflammation in experimental models, but human studies are scarce and
their cutaneous bioavailability and mechanism of photoprotection are unknown. We aimed to examine oral GTC cutaneous uptake, ability
to protect human skin against erythema induced by a UVR dose range and impact on potent cyclo-oxygenase- and lipoxygenase-produced
mediators of UVR inflammation, PGE2 and 12-hydroxyeicosatetraenoic acid (12-HETE), respectively. In an open oral intervention study,
sixteen healthy human subjects (phototype I/II) were given low-dose GTC (540 mg) with vitamin C (50 mg) daily for 12 weeks. Pre-
and post-supplementation, the buttock skin was exposed to UVR and the resultant erythema quantified. Skin blister fluid and biopsies
were taken from the unexposed and the UVR-exposed skin 24 h after a pro-inflammatory UVR challenge (three minimal erythema
doses). Urine, skin tissue and fluid were analysed for catechin content and skin fluid for PGE2 and 12-HETE by liquid chromatography
coupled to tandem MS. A total of fourteen completing subjects were supplement compliant (twelve female, median 42·5 years, range
29–59 years). Benzoic acid levels were increased in skin fluid post-supplementation (P¼0·03), and methylated gallic acid and several
intact catechins and hydroxyphenyl-valerolactones were detected in the skin tissue and fluid. AUC analysis for UVR erythema revealed
reduced response post-GTC (P¼0·037). Pre-supplementation, PGE2 and 12-HETE were UVR induced (P¼0·003, 0·0001). After GTC,
UVR-induced 12-HETE reduced from mean 64 (SD 42) to 41 (SD 32) pg/ml (P¼0·01), while PGE2 was unaltered. Thus, GTC intake results
in the incorporation of catechin metabolites into human skin associated with abrogated UVR-induced 12-HETE; this may contribute to pro-
tection against sunburn inflammation and potentially longer-term UVR-mediated damage.
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UV radiation (UVR) in sunlight is a key environmental stressor
that makes an impact on skin health. Acute effects include sun-
burn (an inflammatory response), immune suppression and
photosensitivity, while repeated exposures lead to photoageing
and photocarcinogenesis(1). Sunburn is characterised clinically
by erythema due to vasodilatation and, histologically, a dermal
infiltrate of neutrophils and mononuclear cells is observed(2,3).
Activation of cutaneous phospholipase A2 by UVR is a key part
of the inflammatory response, releasing membrane-esterified
fatty acids, including arachidonic acid, which is subsequently
metabolised by cyclo-oxygenase (COX), lipoxygenase (LOX)
and cytochrome P450 isozymes to produce eicosanoids
with vasodilatory and chemoattractant properties(4). Potent
pro-inflammatory mediators, PGE2 and 12-hydroxyeicosate-
traenoic acid (12-HETE), are the most abundant eicosanoids at
the peak of the sunburn response, correlating with UVR up-
regulated expression of COX-2 and 12-LOX in human skin(4).
Polyphenols are plant-derived molecules, many exhibiting
anti-inflammatory properties(5,6). Their oral intake is associ-
ated with health benefits, including reduced risk of cancer
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and CVD(7,8). Studies performed largely in experimental
models suggest that polyphenols from various sources may
protect the skin against the adverse effects of UVR, including
carcinogenesis(1,9,10). Green tea is widely consumed world-
wide and contains several polyphenols of the catechin
family, i.e. green tea catechins (GTC), principally (2)-epicate-
chin (EC), (2)-EC-3-O-gallate (ECG), (2)-epigallocatechin
(EGC) and (2)-EGC-3-O-gallate (EGCG(11)). Emerging evi-
dence suggests that GTC can protect against cutaneous
damage. Specifically, oral GTC protected against UVR-induced
skin inflammation and carcinogenesis in hairless mice(12),
whilst in human subjects, topically applied GTC reduced
UVR-induced DNA damage, erythema and leucocytic infil-
trate(13,14), and oral green tea extract reduced skin erythema
following a UVR challenge near the sunburn threshold(15).
Some of these effects may be mediated via effects on COX
and LOX isozymes, as EGCG, EGC, ECG and EC have been
reported to reduce the production of PGE2 and/or 12-HETE
in experimental systems(16–18) and oral GTC to reduce UVR-
induced COX-2 protein expression and PGE2 production in
mouse epidermis(10). However, it is unknown whether these
findings have relevance to human skin.
Despite increasing evidence of their photoprotective poten-
tial, there is a dearth of information on cutaneous bioavailabil-
ity of oral GTC in human subjects, reflecting the challenges of
their tissue assessment. Moreover, the molecular mechan-
ism(s) underlying protection from UVR-induced inflammation
are unexplored in human subjects. Potentially, this may be
conveyed through an impact on key COX- and LOX-derived
pro-inflammatory eicosanoids mediating the sunburn
response, which additionally exhibit promoting properties in
skin carcinogenesis(4,19,20). Thus, the aims of the present
novel study were to examine directly in human subjects
in vivo for evidence of cutaneous uptake of orally adminis-
tered GTC, to evaluate for impact of GTC on sunburn over a
range of pro-inflammatory UVR doses and to explore whether
the underlying mechanism of protection could be GTC modu-
lation of PGE2 and/or 12-HETE formation.
Methods
Subjects and study design
This was an open oral intervention study conducted in the
Photobiology Unit, Dermatology Centre, Salford Royal NHS
Foundation Hospital, Manchester, UK. Subjects (n 16) were
white Caucasian males and females of sun-reactive skin type
I–II (easy sunburn, minimal tanning). The exclusion criteria
were: history of skin cancer or a photosensitivity disorder,
use of a sunbed or sunbathing in the 3 months prior to the
study, taking photoactive medication or nutritional sup-
plements, consuming more than two cups of tea per d and
currently pregnant or breastfeeding. Ethical approval was
obtained from the North Manchester Research Ethics Commit-
tee (reference 08/H1006/79). Written informed consent was
obtained from the participants, and the study adhered to the
Declaration of Helsinki principles.
Dietary supplements
Subjects took oral supplements comprising 540 mg GTC with
50 mg vitamin C daily for 12 weeks. These were in the form
of three capsules, each containing 450 mg green tea extract
(total 1350 mg tea, 540 mg GTC; Table 1) and two capsules
each containing 25 mg vitamin C (total 50 mg vitamin C),
and were taken with breakfast each morning. The low-dose
vitamin C was added to stabilise the green tea extract in the
gut lumen(21); oral vitamin C supplementation alone has
been shown to have no impact on UVR erythema(22).
Supplements were provided by Nestec Limited and packaged
by Laboratoire LPH. Compliance was assessed by counting the
residual capsules in the dispensed containers that the volun-
teers were asked to return and through analysis of 24 h
urine samples collected from all volunteers before and after
1 d, 6 weeks and 12 weeks supplementation.
UV radiation exposure
UVR exposures were performed using a solar simulator, with
emission of UVB and UVA mimicking that of sunlight (emis-
sion 290–400 nm; Newport Spectra-Physics Limited). Irradi-
ance of the light source was measured 10 cm from the
source prior to each irradiation, using a radiometer (model
IL 730A; International Light) calibrated for use with the light
source, to ensure consistency of the doses applied. The mini-
mal erythema dose (MED) of UVR of each subject was
assessed at baseline and post-supplementation, following
application of a geometric series of ten doses of solar-simu-
lated UVR (erythemally weighted doses 6·6–68 mJ/cm2) to
the upper buttock skin (1 cm diameter circular sites). Irra-
diated sites were examined visually after 24 h, with the MED
defined as the lowest dose producing visually discernible
erythema. Erythema at each site was quantified as described
in the following section. At 24 h prior to skin tissue and blister
fluid sampling, doses of UVR of 3 £ the individual’s
pre-supplementation MED were given to sites on one buttock;
this dose was selected in order to provoke an inflammatory
response sufficient to significantly elevate cutaneous eicosa-
noid levels(4).
Table 1. Catechin and gallic acid content of green tea extract*
(Mean values and standard deviations)
Content (mg/450 mg capsule)
GTC Mean SD
Gallic acid 0·4 0·0
Catechin 2·1 0·0
Epicatechin 12·5 0·2
Gallocatechin 12·4 0·6
Epigallocatechin 49·3 3·9
Catechin gallate 0·3 0·0
Epicatechin gallate 26·0 0·2
Gallocatechin gallate 4·5 0·4
Epigallocatechin gallate 72·6 3·1
Total 180·0 8·3
GTC, green tea catechins.
* Contents of three capsules were homogenised and extracted in triplicate.
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Quantification of the UV radiation-induced erythemal
responses
The intensity of erythema (erythema index) was quantified
using a reflectance instrument (Diastron) in ten subjects. Read-
ings were taken in triplicate from each exposed site and from
adjacent unexposed skin, and erythema expressed as the differ-
ence between these readings (DE). Dose–response modelling
was performed using a dedicated data analysis package
(Regional Medical Physics Department, Gateshead & Tyneside
Health Authority, UK) to calculate each subject’s D30, the UVR
dose producing a DE of 30 arbitrary units, a threshold value
that approximates an individual’s visual MED.
Skin biopsy and suction blister fluid sampling
UVR-exposed (3 £ MED) and -protected areas of upper but-
tock skin were sampled at baseline and post-supplementation;
UVR exposures were limited to one buttock and the other but-
tock provided the unexposed skin and blister fluid samples.
Skin punch biopsies (5 mm diameter) were taken after intra-
dermal injection of lignocaine, as described(4), snap-frozen
and stored at 2808C. Suction blisters were raised using suc-
tions cups with a central aperture diameter of 1 cm and
vacuum of 250 mmHg, as described previously(4). Skin blister
fluid was aspirated with a twenty-three-gauge needle, snap-
frozen in liquid N2 and stored at 2808C until analysis. Samples
destined for polyphenol analysis were combined with 25ml
NaH2PO4 (0·4 mol/l, pH 3·6) containing 200 g/l ascorbic acid
and 1 g/l EDTA, prior to freezing.
Eicosanoid analysis
Eicosanoids in skin blister fluid were analysed by liquid chro-
matography coupled to electrospray ionisation tandem MS, as
described previously(23,24). In summary, skin fluid samples
(typically 50–200ml) were diluted with methanol–water
(15 %, w/w) up to 3 ml. Internal standards (40 ng PGB2-d4
and 80 ng 12-HETE-d8; Cayman Chemicals) were then added
and the resultant solutions acidified to pH 3·0, followed by
solid-phase extraction (C18-E cartridges; Phenomenex), to
reduce matrix effects and semi-purify the lipid mediators.
Eicosanoids were analysed on a C18 column (Luna 5mm; Phe-
nomenex) using a Waters Alliance 2695 HPLC pump coupled
to a triple-quadrupole mass spectrometer equipped with an
electrospray ionisation probe (Quattro Ultima; Waters). Instru-
ment control and data acquisition were performed using Mas-
sLynx 4.0 software (Waters). The following multiple reaction
monitoring transitions were used for the assay: PGE2 m/z
351 . 271; 12-HETE m/z 319 . 179.
Polyphenol analysis of urine, skin tissue and blister fluid
Urine was collected in HCl-washed flasks containing ascorbate
(approximately 1 g/l) and stored in aliquots at 2808C. Blister
fluid and urine samples were enzymatically hydrolysed in
line with previous literature(25) with adjustments. Following
thawing at 58C, urine was adjusted to pH 5·0 with NaOH
(0·1 mol/l). A 40ml aliquot of urine or blister fluid was
combined with 4ml NaH2PO4 solution (0·4 mol/l, pH 5·0) con-
taining 200 g/l ascorbic acid and 1 g/l EDTA, and 20ml sodium
acetate buffer (0·2 mol/l, pH 5·0) containing 0·012mg taxifolin
internal standard (Extrasynthese) and 5 U (1.39 nkat) sulpha-
tase (Type VIII; Sigma). Based on previous optimisation
work, 100 and 200 U (0.087 and 0.175 nkat) b-glucuronidase
(Type X; Sigma) in NaH2PO4 (75 mmol/l, pH 6·8) were
added to the blister and urine samples, respectively, and incu-
bated at 378C for 45 and 60 min, respectively. Samples were
extracted with 3 £ 250ml ethyl acetate, with vortexing and
centrifugal separation at each step. The combined extracts
were dried under N2 and frozen at 2808C. Samples and
reagents were handled on ice throughout extraction. Dried
samples were reconstituted with 12ml of 20 % (v/v) aceto-
nitrile containing 1 g/l ascorbic acid, and sealed in a microwell
plate before analysis. With the exception of hippuric acids
(which were poorly partitioned into ethyl acetate), the average
extraction efficiency for catechins and phenolic acids reported
(Table 2) was 84·7 (SD 13·0) %, whilst internal standard extrac-
tion efficiency was consistently at 100 %.
Polyphenol conjugates required extraction from biopsy
tissue before enzyme hydrolysis. Additionally, Chu et al.(26)
highlighted problems using traditional ascorbate/EDTA sol-
utions to stabilise catechins when handling tissue, owing to
intrinsic Fe content, and proposed the use of sodium dithionite,
a reducing agent that does not take part in Fenton reactions.
Biopsies were thawed at room temperature immediately
before extraction and then kept on ice throughout the pro-
cedure. Biopsies were washed in hexane to remove blood
residue. A section of dermis was separated with a scalpel and
weighed. To this, 250ml N2-flushed chloroform containing
0·1 g/l butylated hydroxytoluene and 250ml sodium dithionite
(0·3 mol/l) in sodium acetate buffer (0·2 mol/l, pH 5·0) were
added. Samples were homogenised (Turrax micro homogen-
izer; IKA), with the sample being returned to ice at regular inter-
vals, then vortexed and separated by centrifugation. The
aqueous layer was removed and a second 250ml aliquot of
sodium dithionate in sodium acetate buffer added for a repeat
extraction. Excess chloroform was removed via N2 drying,
and the combined extracts mixed with 50ml sodium acetate
buffer (0·2 mol/l, pH 5·0) containing 0·012mg taxifolin internal
standard, 10 U (2.78 nkat) sulphatase and 200 U (0.175 nkat)
b-glucuronidase. After 60 min incubation at 378C, the extraction
proceeded as for blisters/urine using 3 £ 400ml ethyl acetate.
Samples were analysed using an Agilent 1200 SL HPLC
system (Agilent Technologies), which comprised a binary
pump, degasser, well plate autosampler (58C) and column
oven (358C) connected to a 6410 triple quadrupole
LC-MS/MS. A 5ml aliquot was injected onto a Kinetex C18
microbore column (2·6mm, 150 £ 2·1 mm; Phenomenex) run-
ning a binary gradient of LC-MS-grade water (Millipore)
v. acetonitrile (Fisher), both with 0·2 % (v/v) formic acid, at
0·3 ml/min. The gradient started at 5 % acetonitrile for first
5·8 min, rose to 30 % over 29·2 min and then increased to
95 % acetonitrile over 2·4 min. This was held for a further
3·6 min to wash the column and then returned to 5 % aceto-
nitrile over 3·6 min, re-equilibrating over a further 10·9 min.
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The flow was passed into an electrospray source, with gas
temperature 3508C, flowing at 11 litres/min and with a 30
pounds per square inch (psi) nebuliser pressure. Analytes
were detected in negative mode using dynamic multiple reac-
tion monitoring acquisition. Where available, analyte trans-
mission and MS2 transition parameters were individually
optimised using standards. Internal standards for EC, (þ)-cate-
chin, EGC, ECG, EGCG and taxifolin were obtained from
Extrasynthese. The retention times of gallocatechin, catechin
gallate and gallocatechin gallate were determined by placing
aqueous solutions of the relevant epi-isomers into a boiling
water-bath for 1 h. The chromatographic method did not dis-
tinguish between (þ)- and (2)-enantiomers. The 30 and 40
monomethylated forms of EC and EGC were obtained
from Nacalai Tesque. Benzoic acid, 3-hydoxy benzoic acid,
hippuric acid, 3,4-dihydroxyphenylacetic acid and 3-(20,40-
dihydroxyphenyl) propionic acid were obtained from Fluka
and 4-hydroxy benzoic acid from Aldrich. Vanillic acid, 3,5
dihydroxy benzoic acid, gallic acid, syringic acid, 3- and
4-hydroxyphenyl acetic acids and 3-(30-hydroxyphenyl)-pro-
pionic acid were obtained from Alfa Aesar. 3- and 4-Methyl
gallic acids were obtained from Apin Chemicals, and 2,4-dihy-
droxy benzoic acid, 2,4,6-trihydroxy benzoic acid, 2-hydroxy-
phenyl acetic acid and 2-hydroxy hippuric acid from Acros
Organics. All standards were of HPLC quality (.95 % purity).
As commercial standards for hydroxyphenyl-valerolactones
were not available, these were tentatively identified using pre-
viously reportedMS2 fragment patterns(27). Analyte transmission
and quantifying/qualifying MS2 transition parameters were indi-
vidually optimised using repeat injections of extracted urine.
A total of three hydroxyphenyl-valerolactones were followed,
namely, 5-(30,40,50-trihydroxyphenyl)-g-valerolactone (M4; m/z
223 . 179 þ 138), 5-(30,40-dihydroxyphenyl)-valerolactone
(M6; m/z 207 . 163 þ 122) and 5-(30,50-dihydroxyphenyl)-
valerolactone (M60; m/z 207 . 163 þ 123). M6 v. M60 retention
time was differentiated using a synthetic M6 standard(28),
which was used to quantify all hydroxyphenyl-valerolactones.
Following peak integration, peak areas were normalised to the
internal standard. Whilst response factors for hippuric and ben-
zoic acids were low (on column limit of quantification of 3·45
and 50 pmol, respectively), the universally high levels of
these compounds in urine, skin fluid and tissue meant that
quantification was achievable. The average on column limit of
quantification for all other compounds was 380 (SD 365) fmol.
Statistical analysis
Parametric data were tested using the paired t test. The
Wilcoxon signed-rank test was used for data not satisfying
assumptions of normality. Analyses were performed using
StatsDirect (version 2.7.7, StatsDirect Limited). Statistical sig-
nificance was accepted at P,0·05. Data are shown as means
and standard deviations and presented graphically as means
with their standard errors.
Results
Study subjects and compliance
Of the sixteen subjects recruited to the study, one withdrew
before completion for reasons unrelated to the study.
Table 2. Green tea catechins and their metabolites in urine at baseline and post-supplementation
(Mean values and standard deviations, n 13)
Amount excreted in urine (mmol)
Baseline Day 1 Week 6 Week 12
Compound Mean SD Mean SD Mean SD Mean SD
EC† 0·3 0·4 7* 4 5* 4 7* 5
30-O-Methyl EC† 0·06 0·08 0·6* 0·3 0·5* 0·4 0·6* 0·3
40-O-Methyl EC† 0·04 0·05 0·2** 0·2 0·2** 0·2 0·3* 0·2
ECG 0·000 0·002 0·01* 0·01 0·02* 0·01 0·01** 0·01
EGC† 0·2 0·4 22* 13 20* 16 25* 20
30-O-Methyl EGC† 0·01 0·04 0·2* 0·1 0·2* 0·2 0·2* 0·2
40-O-Methyl EGC† 0 0 8** 8 8** 9 9** 8
EGCG 0·00 0·01 0·06* 0·05 0·06* 0·04 0·08** 0·09
Catechin 0·01 0·02 0·2* 0·1 0·1* 0·1 0·2* 0·2
Gallocatechin 0 0 0·4** 0·5 0·3*** 0·5 0·6** 0·6
Gallocatechin gallate 0 0 0·003 0·009 0 0 0·01* 0·02
Gallic acid 0·6 0·7 1 1 0·7*** 0·5 1** 1
3-O-Methyl gallic acid 0·6 0·6 1 1 0·9 0·8 1*** 1
3-Hydroxybenzoic acid 1 1 2 2 2 3 4*** 4
M4 valerolactone†‡ 0·3 0·4 30** 27 18*** 25 21** 21
M60 valerolactone‡ 0·5 0·7 18** 16 12** 13 15** 15
M6 valerolactone 10 12 33** 25 27*** 28 31*** 24
Syringic acid 2 1 4 5 3 2 4*** 4
Benzoic acid 81 83 95 60 101 132 140*** 120
Hippuric acid 4000 2200 5100 2500 4300 1900 5300*** 1700
EC, epicatechin; ECG, epicatechin-3-O-gallate; EGC, epigallocatechin; EGCG, epigallocatechin-3-O-gallate; M4, 5-(30,40,50-trihydroxyphenyl)-g-valerolactone; M60, 5-(30,50-dihy-
droxyphenyl)-valerolactone; M6, 5-(30,40-dihydroxyphenyl)-valerolactone.
Mean values were significantly different from baseline: *P,0·05, **P,0·01, ***P,0·001 (two-tailed paired t test).
† Increased excretion of metabolite from baseline to week 12 in 100 % of subjects.
‡ M4 and M60 hydroxyphenyl-valerolactone calculated as M6 equivalents.
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The supplement was well-tolerated; four subjects reported
mild nausea following its ingestion. Post-supplementation,
all four major EC and their metabolites were present in the
urine at day 1 and weeks 6 and 12 from fourteen of the fifteen
subjects completing the study (Table 2). Thus, one subject was
non-compliant and fourteen subjects (twelve female), with a
median age of 42·5 years (range 29–59 years), were included
in the study analyses.
Urinary metabolites
Of the thirty-five tea phenolics and metabolites investigated,
t test analysis showed that twenty components were signifi-
cantly higher in week 12 urine samples compared with
baseline (P,0·05; n 13 due to absent record of one sample
volume; Table 2), whilst eight of these were consistently
higher in all participants. As well as several intact catechins,
gallic acid and methylated metabolites, hydroxyphenyl-valero-
lactones, benzoic acid and its glycine conjugate, hippuric acid,
were all increased in the urine following GTC consumption.
Based on a daily intake of 129·2mmol of EC and 482·9mmol
of EGC, average urine excretion of all intact EC and EGC
metabolites (including methylated forms) represented 6·1
and 7·1 % of the dose, respectively.
Skin uptake
Skin fluid and biopsy (dermal) samples were taken from a
subgroup of ten participants at baseline and week 12, and
subjected to qualitative analysis (Table 3). A total of twenty
different phenolic compounds were observed in both
sample types following supplementation. In blister fluid, hip-
puric, benzoic and 4-hydroxybenzoic acids were consistently
present in all ten participants. Interestingly, methylated gallic
Table 3. Presence of green tea catechins and their metabolites in skin
blister fluid and tissue samples post-supplementation (week 12; n 10)†
Skin blister fluid Skin biopsy
Compound
Change
from
average
baseline
value
Detected
in n
participants
Change
from
average
baseline
value
Detected
in n
participants
Benzoic acid þ36 %* 10 ND 10
4-OH-Benzoic acid ND 10 ND 10
Hippuric acid ND 10 ND 6
4-O-Me-gallic acid ND 5 ND 2
EC – – PPS 2
EGC PPS 2 PPS 1
EGC-4-Me – – PPS 4
EGCG – – PPS 1
M4 valerolactone PPS 2 – –
M6 valerolactone PPS 2 – –
ND, no significant difference; EC, epicatechin; PPS, only present post-
supplementation; EGC, epigallocatechin; EGCG, epigallocatechin-3-O-gallate;
M4, 5-(30,40,50-trihydroxyphenyl)-g-valerolactone; M6, 5-(30,40-dihydroxyphenyl)-
valerolactone.
* Value was significantly different compared with baseline (P¼0·03, two-tailed
paired t test).
† Paired t test performed only for compounds present in all subjects.
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Fig. 1. Liquid chromatography–MS/MS total ion current chromatogram of (a)
major compounds in skin fluid and (b) dermal skin tissue extract post-green
tea catechin supplementation (week 12). Peak identities and multiple reaction
monitoring m/z transitions are: 1, M4 hydroxyphenyl-valerolactone
(223 . 179); 2, 4-hydroxybenzoic acid (137 . 93); 3, hippuric acid
(178 . 134); 4, 2,4-dihydroxybenzoic acid (153 . 109); 5, M6 hydroxyphe-
nyl-valerolactone (207 . 163); 6, epicatechin (289 . 245); 7, 3-(30-hydroxy-
phenyl)-propionic acid (165 . 121); and 8, benzoic acid (121 . 77).
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acid and several intact catechins and catechin ring-fission
products were also observed, with 4-O-methyl gallic acid
present in half of the subjects, and EGC, M4 and M6 hydroxy-
phenyl-valerolactones observed in fluid from two participants
(Fig. 1). Change from baseline was only statistically significant
for benzoic acid (P¼0·03). Benzoic acid and its 4-hydroxyl-
ated form were also detected in all biopsy samples, whilst hip-
puric acid was only observed in six volunteers. Following
supplementation, 40-O-methylated EGC (n 4), EGC (n 1), EC
(n 2), EGCG (n 1) and 4-O-methyl gallic acid (n 2) were
observed in the dermis of certain volunteers.
UV radiation erythema dose–response
The median MED was 35 mJ/cm2 at baseline and this was
unchanged post-supplementation. Dose–response analysis
showed a small increase in D30 from a mean of 28·0
(SD 7·7) mJ/cm2 at baseline to 32·9 (SD 11·0) mJ/cm2 post-
supplementation, although this did not reach statistical signifi-
cance (P¼0·17). However, GTC supplementation resulted in
a significant decrease in erythema at the maximum UVR
dose given (68 mJ/cm2 erythemally weighted UVR), with DE
falling from 100·2 (SD 21·4) at baseline to 81·2 (SD 23·2)
post-supplementation (P¼0·006; Fig. 2(a)). AUC analysis of
the UVR erythema dose–response showed a significant
reduction in the erythema response post-supplementation
(P¼0·037; Fig. 2(b)).
Production of PGE2
Pre-supplementation, mean concentration of PGE2 in blister
fluid from unexposed skin was 49·1 (SD 34·9) pg/ml. Pro-
duction of PGE2 significantly increased by approximately
2·3-fold following exposure to 3 £ MED UVR (P¼0·003;
Fig. 3(a)). Post-supplementation, PGE2 in unexposed skin
was similar to baseline (47·5 (SD 30·5) pg/ml). Exposure to
the same UVR dose as at baseline produced a significant rise
in PGE2 (approximately 2·4-fold; P¼0·001), with no significant
difference in PGE2 concentration between exposed skin at
baseline and post-supplementation.
Production of 12-hydroxyeicosatetraenoic acid
Pre-supplementation, the concentration of 12-HETE was sig-
nificantly approximately five-fold higher in UVR-exposed
skin compared with unexposed skin (P¼0·0001). Following
supplementation, the UVR-induced rise in 12-HETE was
approximately 2·7-fold (P¼0·004; Fig. 3(b)), with significantly
lower concentration of 12-HETE in UVR-exposed skin
compared with the baseline (P¼0·01), and no significant
difference in unexposed skin.
Discussion
The present human oral intervention study is novel in several
respects: it evaluates cutaneous uptake of catechins and cate-
chin metabolites, measures the impact of low-dose green tea
supplementation on pro-inflammatory UVR challenges to the
skin and examines the potential for protection through
reduction of pro-inflammatory eicosanoid production. Our
data provide the first evidence that GTC can be taken up
into the skin following oral intake in human subjects and indi-
cate their complex skin incorporation pattern. Significant
reduction was found in the cutaneous UVR erythema dose–
response, with greatest effect at higher doses, and this reduced
inflammation may be attributable to the associated significant
abrogation of UVR up-regulation of the potent pro-inflamma-
tory 12-LOX metabolite, 12-HETE. In contrast, no evidence
was found for mediation of the protection conferred by GTC
through an impact on the COX-2 metabolite PGE2.
The finding that GTC protects against UVR-induced
erythema in human subjects is supported by previous studies
of its topical application(13,14) and a recent oral study(15). In the
latter, volunteers consumed a green tea beverage providing a
much higher dose of 1402 mg catechins/d for 12 weeks, and
this protected against the threshold erythema induced by the
single UVR dose tested. We found a small (non-statistically sig-
nificant) effect at the threshold value D30 and demonstrated
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Fig. 2. Impact of oral green tea catechins on UV radiation-induced erythema.
(a) Erythema response to solar-simulated UV radiation at the D30 and the
highest dose (68 mJ/cm2), before and after 12 weeks supplementation. (b)
UV radiation erythema dose–response curves before (X) and after (B) 12
weeks supplementation. Values are means, with their standard errors rep-
resented by vertical bars (n 10). Mean values were significantly different:
*P,0·05, **P,0·01 (two-tailed paired t test).
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how oral supplementation with GTC can protect against the
inflammation produced over a range of higher UVR doses,
such as can be achieved when individuals over-expose them-
selves to sunlight. Since one large cup of green tea (250 ml)
contains approximately 300 mg of catechins (EC, ECG, EGC
and EGCG), then the modest level of GTC intake in the pre-
sent study, i.e. approximately 540 mg, is seen to be readily
achievable in daily life, and this is already consumed in
many parts of the world.
Compliance with supplement ingestion was confirmed by
demonstration of the urinary content of all four major cat-
egories of catechins in GTC in all but one completing volun-
teer, who was then excluded. As expected, the predominant
intact catechins found in urine were not gallate esters, and
the bioavailability of EC and EGC was in-line with the
reported studies(29,30). GTC intervention resulted in a signifi-
cant increase in the excretion of the majority of intact
catechins from baseline at day 1 and throughout the
12-week study, with no apparent accumulation or adaptive
response during this time. However, the excretion of several
general polyphenol breakdown products, including hippuric,
benzoic and syringic acids, was only significantly elevated
from baseline after 12 weeks of intervention. Hippuric acid
has previously been reported as the primary urinary metab-
olite following both green and black tea intervention, with
participants excreting 3·8 (SD 0·3) and 4·2 (SD 0·3) mmol/
24 h, respectively, following a 6 g/d intervention with tea
solids(31). Whilst hippuric acid was indeed the major urinary
metabolite detected in the present study (5·3 (SD 1·7) mmol/
24 h post-supplementation), its significant increase from base-
line (at week 12) was only in the order of approximately 30 %.
Hippuric acid is a terminal metabolite of benzoic acid, which
itself is a colonic breakdown product common to various phe-
nolic substances. Hippuric acid excretion is therefore not
unique to GTC per se, and its use as a biomarker of catechin
consumption in free-living populations is limited. Hydroxy-
phenyl-valerolactones are catechin metabolites produced by
colonic ring fission: M4 and M60 are predominantly derived
from EGC and M6 from EC(27). Previously, Lee et al.(30)
reported M6 as accounting for 11·2 % of EC dose in eight
human subjects, although considerable variability was
observed in M6 plasma levels. Urinary M4 was reported to
account for just 1·4 % of the EGC dose. In the present study,
M6 accounted for approximately 24 % of EC dose on average
at week 12, with M4 and M60 accounting for approximately
4 % and approximately 3 %, respectively, of the EGC dose.
Levels of hydroxyphenyl-valerolactone excretion were signifi-
cantly increased compared with baseline at day 1 and
throughout the 12 week intervention, without a significant
change in the level of excretion between acute and chronic
GTC consumption. Therefore, we propose that these com-
pounds may serve as a useful biomarker of EC and EGC
intake, over both the short and long term.
Detecting polyphenols and metabolites in tissues is a chal-
lenge, as they bind to proteins, are at low levels and extraction
methods are in development. We discovered that benzoic
acid, its 4-hydroxyl form and its glycine-conjugate, hippuric
acid, were typically present in both skin blister fluid and
dermis. Wide inter-individual differences in oral bioavailability
and metabolism of polyphenols in foods are commonly
reported(30,32). Consistent with this, intact catechins, gallic
acids and catechin ring-fission products were observed in
the skin fluid and dermal samples of some, but not all volun-
teers following GTC supplementation. However, significant
post-supplement increases in blister fluid benzoic acid content
indicates that volunteers experienced an increase in polyphe-
nol metabolites in the target area as a consequence of GTC
intervention, at least partially derived from metabolism by
colonic microflora.
The reduced inflammatory response to UVR on GTC was
associated with significant reduction in UVR induction of the
hydroxy fatty acid, 12-HETE, the most abundant pro-inflam-
matory eicosanoid induced in human skin by UVR exposure.
As well as being a leucocyte chemoattractant, this potent
keratinocyte-derived mediator has been shown to cause a
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Fig. 3. Concentration of (a) PGE2 (n 10) and (b) 12-hydroxyeicosatetraenoic
acid (12-HETE, n 14) in skin fluid from unexposed skin and skin exposed to
3 £ minimal erythema dose (MED) of solar-simulated UV radiation both pre-
and post-supplementation for 12 weeks with green tea catechins. Values are
means, with their standard errors represented by vertical bars. Mean values
were significantly different: *P,0·05, **P,0·01, ***P,0·001 (two-tailed
paired t test for PGE2, Wilcoxon signed-rank test for 12-HETE).
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dose-related erythema when applied to human skin in vivo (33).
While more attention has been focused on the role of PGE2 in
mediating erythema, COX-2 inhibitors only partially suppress
UVR erythema, whilst completely suppressing UVR-induced
PGE2
(34) and LOX-derived mediators could also contribute(35).
Promotion of neutrophil and mononuclear cell migration into
the dermis by 12-HETE may further augment the dermal vaso-
dilatation and leucocytic infiltration through neutrophil release
of vasodilatory NO, reactive oxygen species and chemo-
kines(36). Other antioxidant and cell signalling activities of
GTC may also contribute to reduction of UVR inflam-
mation(1,9), including through modulation of transcription
factor NF-kB(37), NO(19,38) and reduced formation/enhanced
repair of UVR-induced DNA damage(10,14,39).
Our data indicate a direct effect of oral GTC on 12-LOX and/
or possibly cytochrome P450 isoforms producing 12-HETE fol-
lowing UVR, but not on COX-2 (Fig. 4). This contrasts with
studies in prostate and colon cancer cell lines, where the
most abundant polyphenolic compound in tea, EGCG, inhib-
ited protein and/or mRNA expression of COX-2(40,41). How-
ever, EGCG, EGC and ECG are reported to inhibit LOX
activity in colonic mucosa(16) and EC to inhibit activity of
human platelet 12-LOX(17). Topical green tea polyphenols
(1–24 mg in 200ml acetone) in mice reduced the activity of
both LOX and COX enzymes after 12-O-tetradecanoylphor-
bol-13-acetate-induced tumour production, resulting in
decreased PGE2 and 12-HETE production
(42). Differences in
findings are not unexpected between experimental models
and human skin in vivo, and the catechin dose applied
might also influence outcomes(43,44).
UVR is the principal aetiological factor in the majority of
skin cancers, through its actions as a tumour promoter, as
well as an initiator of DNA damage that can lead to mutagen-
esis, and repeated acute UVR insults to the skin are a risk
factor for skin cancer development. Interestingly, 12-HETE is
over-expressed in a variety of human tumours, including
skin cancer, and it has tumour-promoting ability, which is
thought to be conveyed by its anti-apoptotic and angiogenic
properties(45,46). Moreover, inhibitors of 12-HETE are success-
ful in protecting against tumorigenesis in cancer cell lines(47).
This adds to the other evidence, suggesting that GTC may
have potential for development as an effective and safe che-
mopreventive agent in human subjects, as in murine UVR-
induced skin tumours(9).
In summary, the present study indicates that following oral
ingestion, GTC metabolites reach the target organ skin in
human subjects, and that they suppress the biosynthesis of
eicosanoid 12-HETE and sunburn erythema induced by pro-
inflammatory UVR challenges. Manipulation of pro-inflamma-
tory signalling pathways through supplementation with nutri-
tional bioactives is an attractive strategy for photoprotection in
human subjects and may represent a complementary
approach to topical sunscreens, which are infrequently and
generally poorly applied(48). Further studies are indicated to
assess 12-LOX as a molecular target of oral GTC in human
skin, alongside scrutiny for their potential longer-term photo-
protective benefit.
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